Brightstar Therapeutics
PrivateLast Round
Series A
Apr 18, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Brightstar Therapeutics operates in Healthcare & Life Sciences and is based in Lexington, Kentucky. Its latest recorded funding round was a Series A round in April 2023.
Brightstar Therapeutics is a biotechnology company that provides innovative treatment options for people living with corneal and ocular surface diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brightstar Therapeutics Comparables
Compare Brightstar Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CorneaGen | 87% | |
| BioTissue | 84% | |
| Skye Biologics Holdings | 83% |
For institutional investors. Book with your work email.
Brightstar Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Brightstar Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Discovery Capital Funding | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 131% MoM, reaching 2.9K.
- Jul 23, 2026
Grew 38% QoQ, from 8 to 11 employees.
For institutional investors. Book with your work email.
Brightstar Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brightstar Therapeutics's valuation, stock price, and market status.
Is Brightstar Therapeutics a public or private company?
Brightstar Therapeutics is a private company.
What is the current stock price of Brightstar Therapeutics?
Brightstar Therapeutics is a private company, so its shares have no public market price. Caplight tracks Brightstar Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brightstar Therapeutics worth (valuation)?
Valuation information for Brightstar Therapeutics is not publicly available.
Can I buy Brightstar Therapeutics stock?
Brightstar Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brightstar Therapeutics's last funding round?
Brightstar Therapeutics's most recent funding round was Series A on April 18, 2023.
Who are the main investors in Brightstar Therapeutics?
Key investors in Brightstar Therapeutics include Discovery Capital Funding.
Will Brightstar Therapeutics IPO soon?
No public IPO plans have been announced for Brightstar Therapeutics.
How can I track Brightstar Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Brightstar Therapeutics's shares on secondary markets.